Summary by Moomoo AI
KEYSTONE PHARMACEUTICALS SUBMITTED ITS LATEST MONTHLY SECURITIES CHANGE REPORT TO HONG KONG TRADING AND SETTLEMENT LIMITED ON 7 MAY 2024, REPORTING THE CHANGES IN COMPANY SHARES AS OF 30 APRIL 2024. The report showed that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding balance of 2,000,000,000 shares, with a face value of $0.0001 per share and a total regulated/registered share capital of $200,000. In addition, the number of share options under the Initial Public Offering Incentive Plan was unchanged during the month in the Company's stock option program, while 389,830 share options expired after the initial public offering, which amounted to 80,533,501 share options at the end of the month. The report does not mention changes in other types of securities and confirms that all securities issued have been authorized by the Board of Directors and comply with relevant listing rules.